Chordoma: current concepts, management, and future directions (Q28258811)

2

0 references

Ahmed Mohyeldin

3

0 references

Jean-Valery Coumans

4

0 references

Kristopher T Kahle

5

0 references

Manuel J Ferreira

Lancet Oncology Commission

6

0 references

language of work or name

English

0 references

publication date

February 2012

0 references

published in

0 references

volume

13

0 references

issue

2

0 references

page(s)

e69-76

0 references

cites work

Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma and chondrosarcoma gene profile: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma: incidence and survival patterns in the United States, 1973-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Cranial chordomas in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Lumbosacral chordoma. Prognostic factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Three-dimensional reconstruction of human embryonic notochords: clue to the pathogenesis of chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

The pathology of the human notochord

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of brachyury and galectin-3

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

T (brachyury) gene duplication confers major susceptibility to familial chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

A molecular map of mesenchymal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Images in clinical medicine. Chondroid clival chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clival chordoma manifesting as nasal bleeding. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clival chordoma presenting with acute brain stem hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clinicopathologic study of sacrococcygeal chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Current management of sacral chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma of the spine above the sacrum. Treatment and outcome in 21 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Imaging findings in tumors of the sacrum

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Primary tumors of the sacrum: diagnostic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma: A Clinicopathologic Study of Metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Sacral chordoma: 40-year experience at a major cancer center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma: Natural history and treatment results in 33 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma: the nonsarcoma primary bone tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma and chondroid neoplasms of the spheno-occiput: An immunohistochemical study of 41 cases with prognostic and nosologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma: an immunohistologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

High amputation of the sacrum for extirpation of tumors. Principles and technique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

The transnasal transclival approach for clivus chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Ventral surgical approaches to craniovertebral junction chordomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Expanded endoscopic endonasal approach for treatment of clival chordomas: early results in 12 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Endoscopic endonasal transclival resection of chordomas: operative technique, clinical outcome, and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Skull base chordomas: management and results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clinical significance of a wide excision policy for sacrococcygeal chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

1 reference

7 January 2021

Intracranial chordomas: a clinicopathological and prognostic study of 51 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordoma: the results of megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Fractionated proton radiation therapy of cranial and intracranial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Molecular and cellular radiobiology of heavy ions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Base of skull and cervical spine chordomas in children treated by high-dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Proton radiation therapy for chordomas and chondrosarcomas of the skull base

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Carbon ion radiotherapy for unresectable sacral chordomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Gamma Knife surgery for skull base chordomas and chondrosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Stereotactic radiosurgery for chordoma: a report from the North American Gamma Knife Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Should randomized clinical trials be required for proton radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Proton therapy of cancer: potential clinical advantages and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

1 reference

7 January 2021

Charged particles in radiation oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clinical and pathologic review of 48 cases of chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Proton therapy: clinical gains through current and future treatment programs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: acute toxicity and feasibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Complicated surgical resection of malignant tumors in the upper cervical spine after failed ion-beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Clinical Course and Autopsy Findings of a Patient with Clival Chordoma Who Underwent Multiple Surgeries and Radiation during a 10-Year Period

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Characterization and analysis of human chordoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Imatinib mesylate in chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Response to imatinib plus sirolimus in advanced chordoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Response to erlotinib in a patient with treatment refractory chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

A novel target for treatment of chordoma: signal transducers and activators of transcription 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Systemic therapy options for unresectable and metastatic chordomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021

Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970337-0

7 January 2021